2nd Quarter - Report — BUCHANAN INGERSOLL & ROONEY PC for XOMA (2009)

Firm

BUCHANAN INGERSOLL & ROONEY PC

Client

XOMA

Income

$60,000

Expenses

—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate.

Lobbyist	Covered position, as disclosed
DAVID AIMONE	—
STEVEN M HILTON New	—
MARK LENKER	—
BETHANY NOBLE	—
PAUL S QUINN	—
JAMES C WILTRAUT New	—

Contacted: Defense, Dept of (DOD); Homeland Security, Dept of (DHS); Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Pharmacy PHA

Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate.

Lobbyist	Covered position, as disclosed
DAVID AIMONE	—
STEVEN M HILTON New	—
MARK LENKER	—
BETHANY NOBLE	—
PAUL S QUINN	—
JAMES C WILTRAUT New	—

Contacted: Executive Office of the President (EOP); Homeland Security, Dept of (DHS); SENATE; HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS)

Disaster Planning/Emergencies DIS

Biotechnology, Tax, Disaster Palnning, Homeland Security, Science and Technology and Pharmacy issues within the US House and US Senate.

Lobbyist	Covered position, as disclosed
DAVID AIMONE	—
STEVEN M HILTON New	—
MARK LENKER	—
BETHANY NOBLE	—
PAUL S QUINN	—
JAMES C WILTRAUT New	—

Contacted: Homeland Security, Dept of (DHS); Defense, Dept of (DOD); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Homeland Security HOM

Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate.

Lobbyist	Covered position, as disclosed
DAVID AIMONE	—
STEVEN M HILTON New	—
MARK LENKER	—
BETHANY NOBLE	—
PAUL S QUINN	—
JAMES C WILTRAUT New	—

Contacted: Homeland Security, Dept of (DHS); SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate

Lobbyist	Covered position, as disclosed
DAVID AIMONE	—
STEVEN M HILTON New	—
MARK LENKER	—
BETHANY NOBLE	—
PAUL S QUINN	—
JAMES C WILTRAUT New	—

Contacted: Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); SENATE

Science/Technology SCI

Biotechnology, Tax, Disaster Planning, Homeland Security, Science and Technology and Pharmacy issues within the U.S. House and U.S. Senate.

Lobbyist	Covered position, as disclosed
DAVID AIMONE	—
STEVEN M HILTON New	—
MARK LENKER	—
BETHANY NOBLE	—
PAUL S QUINN	—
JAMES C WILTRAUT New	—

Contacted: Defense, Dept of (DOD); Veterans Affairs, Dept of (VA); SENATE; Executive Office of the President (EOP); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.